Hologic features minimally invasive technologies at ACOG annual clinical meeting

Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring minimally invasive technologies in surgical, diagnostic and skeletal health at The American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting. Hologic is one of the largest exhibitors at ACOG, the nation's leading assembly of physicians providing healthcare for women. The meeting is in San Diego, CA May 5-9.

Hologic's GYN Surgical division is highlighting a family of newly developed educational tools and platforms for physicians performing hysteroscopic procedures. Shown for the first time at ACOG is the GyneSim hysteroscopic simulation platform, which provides best practices in training for the MyoSure tissue removal system, fluid management training and troubleshooting for physicians. The MyoSure tissue removal system is an innovative treatment that enables incision-less, fast removal of intrauterine tissue.

Also debuting is Hologic's new Aquilex fluid control system. This high performance system is designed to simplify hysteroscopic fluid management and optimize the MyoSure procedure.

The NovaSure procedure, along with our other procedures, is now featured on drawMD OB/GYN, an iPad application sponsored by Hologic. This iPad app is designed to enhance physician-patient communication by offering an easy, visual way of instantly explaining complex issues and the possible medical and surgical solutions. The app is a free download in the iTunes app store and in the Hologic booth.

Since the introduction of the ThinPrep Pap Test in 1996, Hologic has been dedicated to the prevention of cervical cancer through screening. Over half a billion ThinPrep Pap Testshave been shipped worldwide. Today the ThinPrep Pap Test is the most widely-used liquid based cytology platform in the United States and in many other countries around the world.

The Cervista HPV HR Test is the first high-risk HPV test designed to detect all 14 oncogenic strains of HPV, reduce false-positive results associated with low-risk cross reactivity, and provide an internal control to prevent false negatives. The Cervista HPV 16/18 Test is the first approved HPV genotyping test available in the United States designed to detect and differentiate highly ocogenic and persistent HPV types 16 and 18, which are associated with approximately 70 percent of cervical cancers.

Hologic's unique combination of cytology and molecular products, including the ThinPrep Pap, Cervista HPV HR and Cervista HPV 16/18 tests, provides a full range of cervical cancer screening technologies for improving women's health.

Hologic pioneered dual x-ray absorptiometry (DXA) technology, the industry standard for assessing bone health. At ACOG, the Hologic Skeletal Health division shows how clinicians using the Company's Discovery system can identify fractures not discernible by normal examinations and this same technology can measure body composition and support the diagnosis of heart disease. Hologic's new Advanced Body Composition assessment package offers the obesity and fitness markets the Company's whole body DXA systems which, up to now, have primarily been used to measure osteoporosis in women after they reach menopause.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hologic, Inc.. (2019, June 19). Hologic features minimally invasive technologies at ACOG annual clinical meeting. News-Medical. Retrieved on April 13, 2024 from https://www.news-medical.net/news/20120507/Hologic-features-minimally-invasive-technologies-at-ACOG-annual-clinical-meeting.aspx.

  • MLA

    Hologic, Inc.. "Hologic features minimally invasive technologies at ACOG annual clinical meeting". News-Medical. 13 April 2024. <https://www.news-medical.net/news/20120507/Hologic-features-minimally-invasive-technologies-at-ACOG-annual-clinical-meeting.aspx>.

  • Chicago

    Hologic, Inc.. "Hologic features minimally invasive technologies at ACOG annual clinical meeting". News-Medical. https://www.news-medical.net/news/20120507/Hologic-features-minimally-invasive-technologies-at-ACOG-annual-clinical-meeting.aspx. (accessed April 13, 2024).

  • Harvard

    Hologic, Inc.. 2019. Hologic features minimally invasive technologies at ACOG annual clinical meeting. News-Medical, viewed 13 April 2024, https://www.news-medical.net/news/20120507/Hologic-features-minimally-invasive-technologies-at-ACOG-annual-clinical-meeting.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tepnel Pharma Services uses Hologic’s Invader Plus technology to offer genotyping, CNV service